Expelled AIADMK leader Sasikala tests positive for COVID-19; stable: Hospital
Sasikala, admitted to the Bowring Hospital on Wednesday, is presently in the dedicated COVID-19 Centre of the Victoria Hospital in the city and her condition was stable, hospital sources added.
There’s no evidence of bird flu infecting humans: Sanjeev Balyan
The minister said the disease so far had been reported in five states — Ra...
Take it slow! Fast walking in narrow corridors can increase Covid-19 transmission risk, says study
The scientists warned that the danger is p...
Should I wipe down groceries during the pandemic? Experts say it's not necessary for most people
The coronavirus spreads mainly through the respiratory droplets.
UN health chief: World can start dreaming of pandemic's end
In an address to the U.N. General Assembly's first high-level session on the pandemic, World Health Organization Director-General Tedros Adhanom Ghebreyesus cautioned that while the virus can be stopped, "the path ahead remains treacherous."
Sean Connery's cause of death revealed, actor passed away in sleep due to respiratory failure
The actor had passed away in Bahamas on October 31 at the age of 90.
After varied efficacy data, AstraZeneca to conduct fresh clinical trials of COVID-19 vaccine
AstraZeneca/Oxford said this week it would assess why its vaccine candidate generated better efficacy at a lower dose. The statement came as the British-Swedish drug maker AstraZeneca started rolling submission of data to regulators across the world, while also battling perception about the varied efficacy data from the trial of the vaccine developed jointly with the University of Oxford.
View: The Oxford-AstraZeneca announcement is good news. But we must be careful with the follow-ups
Oxford-AstraZeneca’s vaccine will reportedly offer protection up to 90% in one type of dosage regime, and 62% in another. A 90% efficacy was observed when it was apparently administered as a half dose followed by a full dose at least one month later. This is in contrast to the nearly 95% efficacy announced for both Pfizer’s and Moderna’s anti-Covid vaccines.
Novartis signs $50 million deal for Mesoblast cell therapy for COVID and beyond
The Swiss drugmaker's deal with Australia-based Mesoblast secures rights to develop, commercialize and manufacture Remestemcel-L for treating acute respiratory distress syndrome (ARDS), including that associated with COVID-19, for which the therapy is currently in late-stage trials.
Coronavirus, known as a respiratory virus, can directly infect the heart muscle
In some people, as Covid-19 decreases lung function, it may deprive the heart of adequate oxygen.
Come winter, Covid-19 cases may surge as virus spreads more via respiratory droplets, say scientists
The findings could serve as useful guidance for public health decision-makers.
Covid-19 a respiratory virus, most respiratory viruses escalate during winter: Health Ministry
Addressing the media on Tuesday over the COVID-19 situation in the country, VK Paul, Member (Health), NITI Aayog, said that COVID-19 is a re...
BCG vaccine safe for elderly, can protect against respiratory infections: Study
However the study, published in the journal Cell, cautioned that it is unclear whether the vaccine can prevent COVID-19 in the older sections of the population.
Pranab Mukherjee's respiratory parameters show minor improvement: Hospital
Mukherjee, who was admitted to the Army's Research and Referral Hospital on August 10, developed a lung infection on Wednesday.